TYNEISHIA CUNNINGHAM KING NPI 1235788415

NPI Details

Tyneishia Cunningham King is a family nurse practitioner in Athens, AL with 7 years of experience. Tyneishia Cunningham King NPI is 1235788415. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a female.

The provider's business location address is:

1207 E FORREST ST STE 204D
ATHENS, AL
ZIP 35613-057
Phone: (256) 230-5280
Fax: (256) 427-4117

The NPI 1235788415 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Provision of covid-19 test, nonprescription self-administered and self-collected use, fda approved, authorized or cleared, one test count (HCPCS:K1034)
• Detection test by immunoassay with direct visual observation for influenza virus (HCPCS:87804)
• Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen (HCPCS:87635)
• Injection, ceftriaxone sodium, per 250 mg (HCPCS:J0696)
• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
• Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus (HCPCS:87426)
• Injection of drug or substance under skin or into muscle (HCPCS:96372)
• Established patient home visit, typically 40 minutes (HCPCS:99349)
• New patient office or other outpatient visit, 30-44 minutes (HCPCS:99203)
• Detection test by immunoassay with direct visual observation for respiratory syncytial virus (HCPCS:87807)
• Respiratory infectious agent detection by rna for severe acute respiratory syndrome coronavirus 2 (covid 19), influenza a, influenza b, and respiratory syncytial virus, upper respiratory specimen, each reported as detected or not detected (HCPCS:0241U)
• Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional (HCPCS:99211)
• New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
• New patient home visit, typically 75 minutes (HCPCS:99345)
• New patient office or other outpatient visit, 15-29 minutes (HCPCS:99202)
• Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) (HCPCS:87880)

The enumeration date for this NPI number is 9/10/2019 and was last updated on 3/28/2022.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.